Literature DB >> 3969444

Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts.

J B Little, H Nagasawa.   

Abstract

The effects of confluent holding recovery on survival, chromosomal aberrations, and progression through the life cycle after subculture of human diploid fibroblasts X-irradiated during density inhibition of growth have been examined. The responses of three normal strains were determined and compared with those of four ataxia-telangiectasia (AT), an AT heterozygote, and two hereditary retinoblastoma strains. The capacity for potentially lethal damage repair (PLDR) was slightly reduced in retinoblastoma cells and almost absent in AT cells, but normal in an AT heterozygote. The decline in chromosomal aberrations seen in normal cells during confluent holding was absent in AT cells, consistent with the lack of PLDR. Following subculture, all irradiated AT fibroblasts progressed through the cell cycle to the first mitosis with no delay. AT heterozygotic and retinoblastoma cells showed both an enhanced delay in the initiation of DNA synthesis and a large fraction of cells irreversibly blocked in G1 as compared with normal cells. Both the delayed entry into S and the G1 block were reduced by confluent holding. These results indicate that AT homozygotic and heterozygotic cells respond quite differently to X irradiation.

Entities:  

Mesh:

Year:  1985        PMID: 3969444

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  16 in total

1.  Heterogeneity in the clastogenic response to X-rays in lymphocytes from ataxia-telangiectasia heterozygotes and controls.

Authors:  J K Wiencke; D W Wara; J B Little; K T Kelsey
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

2.  Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.

Authors:  W K Kaufmann; J C Boyer; L L Estabrooks; S J Wilson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks.

Authors:  R S Maser; K J Monsen; B E Nelms; J H Petrini
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

4.  Coordination of the Ser2056 and Thr2609 Clusters of DNA-PKcs in Regulating Gamma Rays and Extremely Low Fluencies of Alpha-Particle Irradiation to G0/G1 Phase Cells.

Authors:  Hatsumi Nagasawa; Yu-Fen Lin; Takamitsu A Kato; John R Brogan; Hung-Ying Shih; Akihiro Kurimasa; Joel S Bedford; Benjamin P C Chen; John B Little
Journal:  Radiat Res       Date:  2017-01-24       Impact factor: 2.841

5.  Transient ATM kinase inhibition disrupts DNA damage-induced sister chromatid exchange.

Authors:  Jason S White; Serah Choi; Christopher J Bakkenist
Journal:  Sci Signal       Date:  2010-06-01       Impact factor: 8.192

6.  G2 chromosomal radiosensitivity in families with ataxia-telangiectasia.

Authors:  Y Shiloh; R Parshad; M Frydman; K K Sanford; S Portnoi; Y Ziv; G M Jones
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

7.  Radioresistant DNA synthesis and human genetic diseases.

Authors:  B R Young; R B Painter
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

8.  Characterization of G1 checkpoint control in the yeast Saccharomyces cerevisiae following exposure to DNA-damaging agents.

Authors:  W Siede; A S Friedberg; I Dianova; E C Friedberg
Journal:  Genetics       Date:  1994-10       Impact factor: 4.562

Review 9.  Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective.

Authors:  J P Murnane
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

10.  Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro.

Authors:  N Cordes; D van Beuningen
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.